Article Type
Review
Published
This article examines omecamtiv mecarbil, which is a first-in-class cardiac myosin activator used in the treatment of heart failure.
Review
This article examines omecamtiv mecarbil, which is a first-in-class cardiac myosin activator used in the treatment of heart failure.
Review
This review aims to present and discuss the current clinical and scientific evidence pertaining to the significance of HDL functionality over the actual HDL-C concentration in mediating the favorable effects on the cardiovascular system.
Editorial
This editorial examines lipocrinology, the study of the interrelationship between lipid metabolism and endocrine function in health and disease
Review
Examines combining a dihydropyridine calcium channel blocker with a renin-angiotensin-aldosterone system inhibitor for the treatment of diabetes
Review
This review aims to present and discuss the current clinical and scientific data pertaining to lipid-lowering interventions targeting PCSK9.